z-logo
open-access-imgOpen Access
Postinjection delirium/sedation syndrome in a transgender man undergoing hormone therapy
Author(s) -
Joshua Gerving,
Heather Walser,
Anne C. Kelly
Publication year - 2022
Publication title -
mental health clinician
Language(s) - English
Resource type - Journals
ISSN - 2168-9709
DOI - 10.9740/mhc.2022.08.263
Subject(s) - medicine , tolerability , olanzapine , hormone therapy , delirium , testosterone (patch) , sedation , intensive care medicine , transgender , schizophrenia (object oriented programming) , pharmacology , adverse effect , psychology , psychiatry , cancer , breast cancer , psychoanalysis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom